SIRT1 in brain aging: molecular mechanisms and therapeutic potential of pharmacological and natural modulators
Biogerontology · 2026
DOI: 10.1007/s10522-026-10480-7 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biogerontology, 2026. Verfasst von Esraa M Mosalam und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of PharmD, Faculty of Pharmacy, Jadara University, Irbid, 21110, Jordan. Hauptthemen laut MEDLINE: Sirtuin 1, Aging, Brain. Die Arbeit nennt 152 Literaturangaben.
Abstract (Originalsprache)
Aging is a multifactorial process affects different tissues and organs and is modulated by genetic and environmental factors. In aging, the frequency of DNA repair errors and genomic instability are augmented. Depletion of endogenous antioxidant capacity during aging promotes the development of oxidative stress which triggers oxidative stress-induced DNA injury. Brain aging is manifested by cognitive impairment and memory disorders. Development of neuronal senescence is the major pathway in the progression of brain aging. Silent information regulator sirtuin 1 (SIRT1) is a class III histone deacetylase plays a critical role in genomic stability during aging. SIRT1 is highly expressed in specific brain regions involved in energy expenditure and metabolic activity that is necessary for brain development and control of brain senescence. Therefore, SIRT1 may have neuroprotective effects against brain aging and related neurodegenerative diseases. This narrative review aims to critically evaluate the role of SIRT1 in brain aging and to summarize current evidence on compounds that directly or indirectly modulate SIRT1 activity, with a focus on their mechanistic pathways and potential therapeutic implications. Findings of the present review highlighted that SIRT1 activators such as resveratrol, metformin and statins have neuroprotective effects against brain aging by regulating inflammatory and oxidative stress disorders through modulation of downstream signaling pathways.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of PharmD, Faculty of Pharmacy, Jadara University, Irbid, 21110, Jordan.
- Department of Pharmaceutical Sciences, Faculty of Pharmacy, Jadara University, Irbid, 21110, Jordan.
- Department of Biochemistry, College of Medicine, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh, Saudi Arabia. ebadr@imamu.edu.sa.
- Pharmacy Practice Department, Faculty of Pharmacy, Horus University, New Damietta, Egypt.
- Pharmacy Practice Department, Faculty of Pharmacy, Mansoura National University, Gamasa, Egypt.
- Scientific Office, Egyptian Society of Pharmacogenomics and Personalized Medicine (ESPM), Cairo, 11562, Egypt.
Zitieren
APA
Mosalam, E. M., Abdallah, M. S., Gardouh, A. R., Hamza, E., Bahaa, M. M., Nazih, M., Al-Dhelaan, R. A., & Kamal, N. (2026). SIRT1 in brain aging: molecular mechanisms and therapeutic potential of pharmacological and natural modulators. Biogerontology. https://doi.org/10.1007/s10522-026-10480-7
Vancouver
Mosalam EM, Abdallah MS, Gardouh AR, Hamza E, Bahaa MM, Nazih M, et al. SIRT1 in brain aging: molecular mechanisms and therapeutic potential of pharmacological and natural modulators. Biogerontology. 2026. doi:10.1007/s10522-026-10480-7
BibTeX
@article{Mosalam2026,
author = {Mosalam, Esraa M and Abdallah, Mahmoud S and Gardouh, Ahmed R and Hamza, Eman and Bahaa, Mostafa M and Nazih, Mahmoud and Al-Dhelaan, Reham A and Kamal, Noha},
title = {SIRT1 in brain aging: molecular mechanisms and therapeutic potential of pharmacological and natural modulators},
journal = {Biogerontology},
year = {2026},
doi = {10.1007/s10522-026-10480-7}
}
EUVIMED